Sorrentino, A. (2026) “CO078 | METABOLOMIC AND LIPOPROTEOMIC MODULATION FOLLOWING INCLISIRAN TREATMENT IN DYSLIPIDEMIC PATIENTS: J. Patrussi1, A. Vignoli1|2, L. Tenori1|2, A. Sorrentino3, M. Berteotti3|4, E. Lotti4, F. Crudele4, G. Ciarrocca Taranta3, A.A. Rogolino4, G. Barbieri3, A.M. Gori3|4, R. Marcucci3|4 | 1Dep. of Chemistry ‘Ugo Schiff’, University of Florence, Sesto Fiorentino, Italy; 2Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; 3Dep. of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; 4Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy”, Bleeding, Thrombosis and Vascular Biology, 5(s3). doi:10.4081/btvb.2026.780.